Free Trial
NASDAQ:QNTM

Quantum Biopharma (QNTM) Stock Price, News & Analysis

Quantum Biopharma logo
$7.08 +0.17 (+2.46%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$6.76 -0.33 (-4.59%)
As of 04/25/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Quantum Biopharma Stock (NASDAQ:QNTM)

Key Stats

Today's Range
$6.77
$7.24
50-Day Range
$4.22
$8.56
52-Week Range
$2.70
$18.00
Volume
49,757 shs
Average Volume
1.10 million shs
Market Capitalization
$19.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Receive QNTM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quantum Biopharma and its competitors with MarketBeat's FREE daily newsletter.

QNTM Stock News Headlines

Quantum BioPharma adds Kevin Malone as advisor
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
Quantum Group appoints Malone as advisor to Board of Directors
See More Headlines

QNTM Stock Analysis - Frequently Asked Questions

Quantum Biopharma's stock was trading at $3.68 at the beginning of the year. Since then, QNTM stock has increased by 92.4% and is now trading at $7.08.
View the best growth stocks for 2025 here
.

Quantum Biopharma Ltd. (NASDAQ:QNTM) released its quarterly earnings data on Friday, March, 28th. The company reported ($2.89) earnings per share for the quarter, missing the consensus estimate of ($0.80) by $2.09.

Shares of QNTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Quantum Biopharma investors own include Jiuzi (JZXN), Aethlon Medical (AEMD), Aditxt (ADTX), Adial Pharmaceuticals (ADIL), Avalon GloboCare (ALBT), Ainos (AIMD) and AMC Entertainment (AMC).

Company Calendar

Last Earnings
3/28/2025
Today
4/26/2025
Next Earnings (Estimated)
5/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:QNTM
Previous Symbol
NASDAQ:QNTM
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-17,900,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$21.29 per share
Price / Book
0.33

Miscellaneous

Free Float
1,755,000
Market Cap
$19.16 million
Optionable
N/A
Beta
0.37
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:QNTM) was last updated on 4/27/2025 by MarketBeat.com Staff
From Our Partners